Prescription drug · ANDA
Doxazosin NDC 50090-0701
Doxazosin mesylate 1 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-0701-0 | 5009007010050090070100 | 30 TABLET in 1 BOTTLE (50090-0701-0)Marketed from Nov 28, 2014 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxazosin
- Generic name (nonproprietary)
- doxazosin
- Active ingredients
- Doxazosin mesylate — 1 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075580
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 50090-0701_e4e04ecc-a6d1-41dd-bbdc-b4f462b4ca9bSPL ID e4e04ecc-a6d1-41dd-bbdc-b4f462b4ca9b
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090070100followed by a unit qualifier and the quantityPackage 50090-0701-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 50090-0701
- What is NDC 50090-0701?
- 50090-0701 is the product NDC for Doxazosin, Doxazosin mesylate 1 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Doxazosin.
- What is the active ingredient?
- Doxazosin mesylate.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Doxazosin?
- 106 other product NDCs are listed under this name. See all Doxazosin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Doxazosin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-166 | 16571-0166-01 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-165 | 16571-0165-01 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-167 | 16571-0167-01 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-168 | 16571-0168-01 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-892 | 59651-0892-0159651-0892-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-893 | 59651-0893-0159651-0893-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-894 | 59651-0894-0159651-0894-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-895 | 59651-0895-0159651-0895-99 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4031 | 70518-4031-00 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3965 | 70518-3965-0070518-3965-01 |
Other NDCs under ANDA 075580
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Major Pharmaceuticals | 0904-5522 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Major Pharmaceuticals | 0904-5523 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Major Pharmaceuticals | 0904-5524 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | AvKARE | 42291-258 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | AvKARE | 42291-259 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | AvKARE | 42291-260 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-739 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | A-S Medication Solutions | 50090-0704 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | AvPAK | 50268-222 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | AvPAK | 50268-223 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | AvPAK | 50268-224 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | AvPAK | 50268-225 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-476 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-7996 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Apotex Corp. | 60505-0093 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Apotex Corp. | 60505-0094 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Apotex Corp. | 60505-0095 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Apotex Corp. | 60505-0096 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3298 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3341 |
Showing 20 of 33.